| Financial Year |
March 31 2023 |
| Monetary Funds |
27,439,338.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,399,432.73 |
| Accounts Receivable |
263,425,310.36 |
| Advances to Suppliers |
13,451,266.59 |
| Other Receivables |
443,884.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
358,320,928.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,715,803.49 |
| Total Current Assets |
688,411,237.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
112,482,295.58 |
| Under-construction Projects |
47,923,575.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,488,832.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,443,345.07 |
| Deferred Income Tax Assets |
5,281,069.09 |
| Other Non-Current Assets |
11,525,092.39 |
| Sub-Total of Non-Current Assets |
233,144,209.49 |
| Total Assets |
921,555,447.21 |
| Short-Term Loans |
245,109,236.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,000,000.00 |
| Accounts Payable |
37,409,429.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,153,935.74 |
| Taxes Payable |
2,701,624.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
-- |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
173,884.05 |
| Sub-Total of Current Liabilities |
296,885,679.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,338,134.44 |
| Other Non-Current Liabilities |
719,106.49 |
| Sub-Total of Non-Current Liabilities |
2,057,240.93 |
| Total Liabilities |
298,942,920.06 |
| Paid-In Capital(Or Share Stock) |
84,000,000.00 |
| Capital Surplus |
352,882,270.57 |
| Surplus Reserve |
20,249,057.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
165,481,199.27 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
622,612,527.15 |
| Owner's Equity（Stockholder's Equity） |
622,612,527.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
921,555,447.21 |
